<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rodriguez-Calvo J</submitter><funding>Instituto de Salud Carlos III</funding><pagination>181-190</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10107431</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>61(2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To analyze the ability to predict perinatal survival and severe neonatal morbidity of cases with early-onset fetal growth restriction (eoFGR) using maternal variables, ultrasound parameters and angiogenic markers at the time of diagnosis.&lt;h4>Methods&lt;/h4>This was a prospective observational study in a cohort of singleton pregnancies with a diagnosis of eoFGR (&lt; 32 weeks of gestation). At diagnosis of eoFGR, complete assessment was performed, including ultrasound examination (anatomy, biometry and Doppler assessment) and maternal serum measurement of the angiogenic biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF). Logistic regression models for the prediction of perinatal survival (in cases diagnosed at &lt; 28 weeks) and severe neonat</pubmed_abstract><journal>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</journal><pubmed_title>Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor.</pubmed_title><pmcid>PMC10107431</pmcid><funding_grant_id>PI13/02405</funding_grant_id><pubmed_authors>Herraiz I</pubmed_authors><pubmed_authors>Galindo A</pubmed_authors><pubmed_authors>Quezada MS</pubmed_authors><pubmed_authors>Villalain C</pubmed_authors><pubmed_authors>Gomez-Arriaga PI</pubmed_authors><pubmed_authors>Rodriguez-Calvo J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor.</name><description>&lt;h4>Objective&lt;/h4>To analyze the ability to predict perinatal survival and severe neonatal morbidity of cases with early-onset fetal growth restriction (eoFGR) using maternal variables, ultrasound parameters and angiogenic markers at the time of diagnosis.&lt;h4>Methods&lt;/h4>This was a prospective observational study in a cohort of singleton pregnancies with a diagnosis of eoFGR (&lt; 32 weeks of gestation). At diagnosis of eoFGR, complete assessment was performed, including ultrasound examination (anatomy, biometry and Doppler assessment) and maternal serum measurement of the angiogenic biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF). Logistic regression models for the prediction of perinatal survival (in cases diagnosed at &lt; 28 weeks) and severe neonat</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-27T02:36:42.461Z</modification><creation>2025-04-06T18:38:01.727Z</creation></dates><accession>S-EPMC10107431</accession><cross_references><pubmed>36370447</pubmed><doi>10.1002/uog.26116</doi></cross_references></HashMap>